Previous 10 | Next 10 |
MacroGenics (NASDAQ: MGNX ) sinks 6.1% in premarket trading after Morgan Stanley analyst David Lebowitz cuts his rating to underweight from equal-weight. More news on: MacroGenics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
SAN FRANCISCO, CA / ACCESSWIRE / November 12, 2019 / Hagens Berman alerts MacroGenics (NASDAQ:MGNX) investors of today's lead plaintiff deadline to move for lead plaintiff in a federal securities class action against the company and urges MGNX investors who have suffered losses in excess...
SAN FRANCISCO, CA / ACCESSWIRE / November 11, 2019 / Hagens Berman urges MacroGenics (NASDAQ:MGNX) investors who have suffered losses in excess of $50,000 to submit their losses now to learn if they qualify to recover their investment losses. Only one day remains until tomorrow's Nove...
MacroGenics, Inc. (MGNX) Q3 2019 Earnings Conference Call November 6, 2019 16:30 ET Company Participants Anna Krassowska - Vice President, Investor Relations and Corporate Communications Scott Koenig - President and Chief Executive Officer Jim Karrels - Senior Vice President and ...
SAN FRANCISCO, Nov. 10, 2019 (GLOBE NEWSWIRE) -- Hagens Berman urges MacroGenics (NASDAQ: MGNX) investors who have suffered losses in excess of $50,000 to submit their losses now to learn if they qualify to recover their investment losses. Only two days remain until the November 12, ...
AN FRANCISCO, CA / ACCESSWIRE / Novemver 9, 2019 / Hagens Berman urges MacroGenics (NASDAQ:MGNX) investors who have suffered losses in excess of $50,000 to submit their losses now to learn if they qualify to recover their investment losses. The November 12, 2019 lead plaintiff deadl...
SAN FRANCISCO, CA / ACCESSWIRE / November 8, 2019 / Hagens Berman urges MacroGenics (NASDAQ:MGNX) investors who have suffered losses in excess of $50,000 to submit their losses now to learn if they qualify to recover their investment losses. The November 12, 2019 lead plaintiff deadlin...
New York, New York--(Newsfile Corp. - November 8, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in MacroGenics, Inc. (NASDAQ: MGNX) ("MacroGenics" or the "Company") of the November 12, 2019 deadline to seek the role of lead plaintiff in a federal s...
Image source: The Motley Fool. Macrogenics Inc (NASDAQ: MGNX) Q3 2019 Earnings Call Nov 6, 2019 , 4:30 p.m. ET Operator Continue reading
SAN FRANCISCO, CA / ACCESSWIRE / November 6, 2019 / Hagens Berman urges MacroGenics (NASDAQ: MGNX) investors who have suffered losses in excess of $50,000 to submit their loss now to learn if they qualify to recover their investment losses. The November 12, 2019 lead plaintiff deadline...
News, Short Squeeze, Breakout and More Instantly...
SAN FRANCISCO, July 19, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges MacroGenics, Inc. (NASDAQ: MGNX) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/mgnx Contact the Firm Now: MGNX@hbsslaw.com 844-916...
MacroGenics, Inc. (NASDAQ: MGNX) is the focus of IBN's latest stock spotlight. The company's shares have moved 1.07% on the day to $4.7. MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved pr...
SAN FRANCISCO, July 03, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges MacroGenics, Inc. (NASDAQ: MGNX) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/mgnx Contact the Firm Now: MGNX@hbsslaw.com 844-916...